======= HOXA9 ======= == Gene Information == * **Official Symbol**: HOXA9 * **Official Name**: homeobox A9 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3205|3205]] * **UniProt**: [[https://www.uniprot.org/uniprot/P31269|P31269]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HOXA9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXA9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142956|Open OMIM]] == Function Summary == * **Entrez Summary**: In vertebrates, the genes encoding the class of transcription factors called homeobox genes are found in clusters named A, B, C, and D on four separate chromosomes. Expression of these proteins is spatially and temporally regulated during embryonic development. This gene is part of the A cluster on chromosome 7 and encodes a DNA-binding transcription factor which may regulate gene expression, morphogenesis, and differentiation. This gene is highly similar to the abdominal-B (Abd-B) gene of Drosophila. A specific translocation event which causes a fusion between this gene and the NUP98 gene has been associated with myeloid leukemogenesis. Read-through transcription exists between this gene and the upstream homeobox A10 (HOXA10) gene.[provided by RefSeq, Mar 2011]. * **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Required for induction of E-selectin and VCAM-1, on the endothelial cells surface at sites of inflammation. {ECO:0000269|PubMed:22269951}. |Hox9 act| |Homeobox| |endothelial cell activation| |definitive hemopoiesis| |uterus development| |proximal/distal pattern formation| |embryonic forelimb morphogenesis| |forelimb morphogenesis| |negative regulation of myeloid cell differentiation| |embryonic appendage morphogenesis| |embryonic limb morphogenesis| |embryonic skeletal system development| |mammary gland development| |male gonad development| |development of primary male sexual characteristics| |negative regulation of hemopoiesis| |single fertilization| |appendage morphogenesis| |limb morphogenesis| |male sex differentiation| |fertilization| |limb development| |appendage development| |transcription factor complex| |gonad development| |development of primary sexual characteristics| |anterior/posterior pattern specification| |regulation of myeloid cell differentiation| |sex differentiation| |regionalization| |enzyme binding| |gland development| |reproductive structure development| |reproductive system development| |pattern specification process| |negative regulation of immune system process| |regulation of hemopoiesis| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |spermatogenesis| |hemopoiesis| |male gamete generation| |embryonic morphogenesis| |hematopoietic or lymphoid organ development| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |immune system development| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |developmental process involved in reproduction| |gamete generation| |negative regulation of cell differentiation| |multicellular organismal reproductive process| |sexual reproduction| |multicellular organism reproduction| |negative regulation of developmental process| |embryo development| |multi-organism reproductive process| |cell activation| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |organic cyclic compound biosynthetic process| |reproductive process| |reproduction| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-2.42| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-1.91| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.74| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|1.74| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|1.74| |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.81| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.88| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.11| |[[:results:exp33|Rotenone 2μM R00 exp33]]|2.37| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|3.31| |[[:results:exp93|DABN racemic mixture R03 exp93]]|4.54| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14876 * **Expression level (log2 read counts)**: -6.02 {{:chemogenomics:nalm6 dist.png?nolink |}}